@article{ba08ddbd49cc43c3b524760324237daa,
title = "LRRK2 R1441C mutation causing Parkinson{\textquoteright}s Disease in an Egyptian family",
keywords = "Egyptian, Parkinson{\textquoteright}s Disease, R1441C mutation, leucine-rich repeat kinase 2 gene",
author = "Shan Ali and Wszolek, {Zbigniew K.}",
note = "Funding Information: yses under approval of the institutional review board (IRB) of Mayo Clinic Florida. Written informed consent was obtained. We confirm that we have read the Journal{\textquoteright}s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Financial disclosure/conflict of interest: ZKW is partially supported by the NIH/NIA and NIH/NINDS (1U19AG063911, FAIN: U19AG063911), Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, gifts from the Sol Goldman Charitable Trust, and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases Fund, and the Albertson Parkinson{\textquoteright}s Research Foundation. He serves as PI or Co-PI on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), Neuraly, Inc. (NLY01-PD-1), and Vigil Neuroscience, Inc. (VGL101-01.001) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for Vigil Neuroscience, Inc.; SA has nothing to disclose. Funding: None.",
year = "2022",
doi = "10.5603/PJNNS.a2022.0008",
language = "English (US)",
volume = "56",
pages = "191--192",
journal = "Neurologia i Neurochirurgia Polska",
issn = "0028-3843",
publisher = "Termedia Publishing House Ltd.",
number = "2",
}